Skip to main content

Advertisement

  • Correction
  • Open Access

Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial

  • 1,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 8,
  • 9, 10,
  • 11Email author,
  • 12 and
The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201819:120

https://doi.org/10.1186/s10194-018-0949-9

  • Received: 14 November 2018
  • Accepted: 14 November 2018
  • Published:

The original article was published in The Journal of Headache and Pain 2018 19:101

Correction

Following publication of the original article [1], the authors notified us that the citation within the Table 1 legend was not presented as initially requested. Also, the word “efficacy” was missed from the background section.

The original publication has been corrected. The incorrect and correct table citations as well as background information are presented below.
  • Originally published citation:

© 2018 Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Dorlas S, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P, PRESTO Study Group (2018) Non-invasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study [published online June 15, 2018]. Neurology:doi:https://doi.org/10.1212/WNL.0000000000005857. www.neurology.org. Adapted with permission

Abbreviations: DB Double-blind, NA Not applicable, nVNS Non-invasive vagus nerve stimulation, SD Standard deviation

aNo. of days the patient typically takes acute migraine medication per month. bPatients with no reported baseline severity were excluded from this analysis
  • Corrected citation:

© 2018 Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364-e373. Adapted with permission
  • Original Background paragraph:

Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented but remain frequently used in the emergency department setting, which significantly increases healthcare costs
  • Corrected Background paragraph:

Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented efficacy but remain frequently used in the emergency department setting, which significantly increases healthcare costs

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy
(2)
Headache and Pain Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Pisana, Rome, Italy
(3)
Neuroalgology Unit, Carlo Besta Neurological Institute and Foundation, Milan, Italy
(4)
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
(5)
Department of Neuroscience, University of Turin, Turin, Italy
(6)
Headache Centre, University Hospital of Careggi, Florence, Italy
(7)
IRCCS Neuromed, Pozzilli, IS, Italy
(8)
Neurologic Clinic, Santa Maria della Misericordia Hospital, Perugia, Italy
(9)
Headache Science Centre, IRCCS C. Mondino Foundation, Pavia, Italy
(10)
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
(11)
electroCore, Inc., Basking Ridge, NJ, USA
(12)
Neurophysiology and Pain Unit, University of Bari Aldo Moro, Bari, Italy

Reference

  1. Martelletti P et al (2018) Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 19:101. https://doi.org/10.1186/s10194-018-0929-0 View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2018

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement